Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biolargo Inc BLGO

Chemicals Specialty Chemicals
BioLargo, Inc. is a cleantech and life sciences innovator and engineering services solution provider. The Company operates through six segments: ONM Environmental, Clyra Medical Technologies (Clyra Medical), BioLargo Engineering (BLEST), BioLargo Canada, Inc. (Canada), BioLargo Energy Technologies, Inc. (BETI), and BioLargo Equipment Solutions & Technologies, Inc. (BEST). ONM Environmental... see more

Recent & Breaking News (OTCQX:BLGO)

BioLargo Achieves 185% Growth to $1.3 Million Revenue for Second Quarter 2022, as Published in Quarterly Report

Accesswire August 16, 2022

BioLargo Q2 2022 Earnings Results Webcast and Conference Call on Wednesday, August 17, 2022 - 4 PM Eastern Time

Accesswire August 12, 2022

BioLargo Secures First PFAS Mitigation Customer and Signs New Channel Partner for PFAS Remediation

Accesswire August 11, 2022

BioLargo Sets New Quarterly Revenue Record

Accesswire August 3, 2022

BioLargo Engineering, Science & Technologies Selected to Help Make Novel Nuclear Reactor Fuel Production System

Accesswire June 30, 2022

BioLargo to Present at the LD Micro Invitational XII Investor Conference on June 7-9, 2022

Newsfile May 31, 2022

BioLargo, Inc. Discusses Record-Breaking Quarter on The Stock Day Podcast

Newsfile May 23, 2022

BioLargo Q1 2022 Earnings Results Webcast and Conference Call on Thursday, May 19, 2022 - 4:00 PM Eastern Time

Accesswire May 17, 2022

BioLargo's First Quarterly Report of 2022 Highlights: Record Company-wide Revenues, Subsidiaries Achieving and Approaching Profitability, and Progress of Key Growth Catalysts

Accesswire May 17, 2022

BioLargo Continues Growth Trend by Breaking Quarterly Revenue Record

Accesswire April 20, 2022

BioLargo Annual Earnings Results Webcast and Conference Call Monday, April 4, 2022 - 4:30 PM Eastern Time

Accesswire April 1, 2022

BioLargo Annual Report for 2021 Highlights Active Commercial Catalysts, Expanding Partnerships, and Improved Balance Sheet

Accesswire March 31, 2022

BioLargo Provides Progress Report on Major Growth Catalysts

Accesswire February 17, 2022

BioLargo, Inc. Discusses Progress of Key Partnerships and its PFAS Treatment Technology with The Stock Day Podcast

Newsfile February 3, 2022

BioLargo's PFAS Removal System Achieves Total Elimination of Multiple PFAS Compounds in Testing with Client Water

Accesswire December 23, 2021

BioLargo, Inc. Discusses Development and Scale-Up of Its PFAS Treatment Technology and 2022 Commercial Plans With The Stock Day Podcast

Newsfile December 16, 2021

BioLargo Begins Next Step in Preparing Garratt-Callahan Minimal Liquid Discharge System for Commercial Launch

Accesswire December 8, 2021

BioLargo Signs Manufacturer's Representative Agreement with ICS Group for its Innovative Water Treatment Technologies

Accesswire December 1, 2021

BioLargo Strategic Partnership with Ikigai to Launch New Consumer Product

Accesswire November 30, 2021

BioLargo's Third Quarterly Report for 2021 Details Progress of PFAS Technology Commercialization and Ongoing Partnerships

Accesswire November 16, 2021